PROCEPT BioRobotics Corp financial data

Symbol
PRCT on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
150 Baytech Drive, San Jose, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 28, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 732 % -4.96%
Quick Ratio 97.3 % -7.35%
Debt-to-equity 48 % -14.2%
Return On Equity -38.6 % +25.3%
Return On Assets -26.1 % +21.3%
Operating Margin -53.3 % +40.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.2M shares +3.34%
Common Stock, Shares, Outstanding 52.1M shares +3.32%
Entity Public Float 1.4B USD +40%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 52M shares +7.66%
Weighted Average Number of Shares Outstanding, Diluted 52M shares +7.66%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 200M USD +71.7%
Cost of Revenue 85.2M USD +52.3%
Research and Development Expense 61.7M USD +41.5%
Operating Income (Loss) -106M USD -1.73%
Net Income (Loss) Attributable to Parent -100M USD +6.1%
Earnings Per Share, Basic -1.95 USD/shares +16.3%
Earnings Per Share, Diluted -1.95 USD/shares +16.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 197M USD -31.5%
Accounts Receivable, after Allowance for Credit Loss, Current 69M USD +99.4%
Inventory, Net 50.9M USD +20.5%
Assets, Current 323M USD -12.4%
Property, Plant and Equipment, Net 26.6M USD -1.58%
Operating Lease, Right-of-Use Asset 19.3M USD -6.92%
Other Assets, Noncurrent 1.25M USD +201%
Assets 374M USD -11.2%
Accounts Payable, Current 15.1M USD +11%
Contract with Customer, Liability, Current 7.99M USD +59.6%
Liabilities, Current 53.6M USD +29.7%
Contract with Customer, Liability, Noncurrent 517K USD
Operating Lease, Liability, Noncurrent 27.4M USD +2.36%
Other Liabilities, Noncurrent 479K USD
Liabilities 133M USD +9.16%
Accumulated Other Comprehensive Income (Loss), Net of Tax -18K USD -200%
Retained Earnings (Accumulated Deficit) -527M USD -23.4%
Stockholders' Equity Attributable to Parent 241M USD -19.4%
Liabilities and Equity 374M USD -11.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32.3M USD +10.1%
Net Cash Provided by (Used in) Financing Activities 2.59M USD +581%
Net Cash Provided by (Used in) Investing Activities -1.95M USD +63.6%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 52.1M shares +3.32%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -31.6M USD +22.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 200M USD -31.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1M USD -10.4%
Deferred Tax Assets, Valuation Allowance 121M USD +29.1%
Deferred Tax Assets, Gross 126M USD +26.6%
Operating Lease, Liability 29.2M USD +2.7%
Payments to Acquire Property, Plant, and Equipment 1.95M USD -63.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -100M USD +6.29%
Lessee, Operating Lease, Liability, to be Paid 41.8M USD -9.53%
Property, Plant and Equipment, Gross 33.4M USD -12.7%
Operating Lease, Liability, Current 1.84M USD +8.05%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.43M USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.3M USD +2.73%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.6M USD -29.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.81M USD +8.63%
Deferred Tax Assets, Operating Loss Carryforwards 80.3M USD +23.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 3.39M USD +25.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.95M USD +3%
Additional Paid in Capital 768M USD +5.77%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 300K USD 0%
Depreciation, Depletion and Amortization 1.18M USD +49.3%
Deferred Tax Assets, Net of Valuation Allowance 4.96M USD -14.9%
Share-based Payment Arrangement, Expense 27.7M USD +62.8%
Interest Expense 4.15M USD -10.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%